Thorsten Koch

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed et al. · The Lancet · 2018 · 1.7K citations · Full text

Diabetes Management, Cardiovascular Disease, Diabetes +6

Tumour necrosis factor‐alpha plasma level in patients with type 1 diabetes mellitus and its association with glycaemic control and cardiovascular risk factors

Monika Lechleitner, Thorsten Koch, Manfred Herold et al. · Journal of Internal Medicine · 2000 · 178 citations

Trastuzumab in the treatment of elderly patients with early breast cancer: Results from an observational study in Germany

Peter Dall, G Lenzen, Thomas Göhler et al. · Journal of Geriatric Oncology · 2015 · 34 citations

Prognostic Value of Antibody Titre to Heat-Shock Protein 65 on Cardiovascular Events

Friedrich Hoppichler, Thorsten Koch, Alexander Dzien et al. · Cardiology · 2000 · 34 citations

Vascular Disease, Immunology, Pathology +22

Trastuzumab without chemotherapy in the adjuvant treatment of breast cancer: subgroup results from a large observational study

Peter Dall, Thorsten Koch, Thomas Göhler et al. · BMC Cancer · 2018 · 17 citations · Full text